Volume 5, Issue 1, Spring 2026

Afficher Volume 5, Issue 1, Spring 2026
  • Current Management of Relapsed or Refractory Classic Hodgkin Lymphoma in Canada
  • Approach to Patients with Acute Myeloid Leukemia in First Relapse: A Practical Guide for Canadian Hematologists
  • Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape
  • Is Continuous Therapy Becoming Finite? The Evolving Landscape of CLL Treatment in 2026
  • High-Risk Multiple Myeloma in 2026: Evolving Definitions and Therapeutic Options
Publié: 2026-06-10

Numéro complet

Articles